Skip to content

the effects of ultrasound-guided fascia iliac block with different doses of butorphanol combined with ropivacaine on postoperative analgesia in elderly patients undergoing intertrochanteric fracture surgery

the effects of ultrasound-guided fascia iliac block with different doses of butorphanol combined with ropivacaine on postoperative analgesia in elderly patients undergoing intertrochanteric fracture surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095445
Enrollment
Unknown
Registered
2025-01-07
Start date
2025-01-09
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intertrochanteric fracture of the femur

Interventions

B:Fascia iliac block with 0.5mg butorphanol combined with ropivacaine
C:Fascia iliac block with 1mg butorphanol combined with ropivacaine
A:Fascia iliaca block with ropivacaine
D:Fascia iliac block with 1.5mg butorphanol combined with ropivacaine

Sponsors

Fuzhou Changle District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1 .Sex is not limited age >=60 years old; 2.Clear history of trauma post-injury manifestations such as joint pain swelling and activity limitation X-ray or MRI examination suggesting intertrochanteric fracture of the femur and indications for closed reduction intramedullary nail internal fixation of femur fracture surgery; 3. American Society of Anesthesiologists (ASA) grade I to III; 4. No serious diseases of the heart brain lungs liver kidneys and other organs; 5. Each patient could understand and accurately judge the visual analog score (VAS) of pain; 6.Each patient had no history of sedative-analgesic drug abuse or drug exposure.

Exclusion criteria

Exclusion criteria: 1.Body mass index (BMI) > 30 kg/ m^2; 2.Compound other parts of the pathological fracture or rheumatoid arthritis; 3.Compound craniocerebral injury systemic infection and localized osteomyelitis etc; 4.Patients with infection skin damage or hematoma at the puncture site; 5.Poor basic condition unable to tolerate surgery or high risk of surgery; 6.History of allergy to amide local anesthetics; 7.Have taken hormonal drugs analgesic drugs and drugs interfering with adrenal function anti-sympathetic nerves or psychotropic drugs in the past six months; 8. Concomitant psychiatric disorders or cognitive impairment or communication difficulties; 9.Patients with sinus bradycardia and atrioventricular block; 10 .Patients taking long-term ß-blockers; 11. Patients with coagulation disorders: activated partial thrombin time (APTT) prothrombin time (PT) >1.5 times the upper limit of normal.

Design outcomes

Primary

MeasureTime frame
Duration of rest analgesia;Duration of passive movement analgesia;

Secondary

MeasureTime frame
VAS scores at rest after 6h,8h,12h,24h,48h of fascia iliaca block;VAS scores during passive movement after 6h,8h,12h,24h,48h of fascia iliaca block;Ramsay sedation score after 6h,8h,12h,24h,48h of fascia iliacus block;The incidence of postoperative adverse reactions (sinus bradycardia hypotension nausea vomiting hypoxemia etc.);The first time to get out of bed after operation;The number of effective compressions of intravenous analgesia pump within 48 hours;Dose of rescue analgesics;Length of stay in hospital;

Countries

China

Contacts

Public ContactYunyun Xu

Fuzhou Changle District People's Hospital

1061713252@qq.com+86 156 5989 1499

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026